EXHIBIT 10.10

                              INVESTMENT AGREEMENT


THIS INVESTMENT AGREEMENT (this "Agreement") dated as of March 21, 2002, is made
and entered into by and among:

EUGENE SCIENCE INC., a corporation  organized and existing under the laws of the
Republic of Korea,  having its  principal  office at 8th Fl.,  LG Palace  Bldg.,
165-8 Donggyo-Dong, Mapo-Gu, Seoul, Korea ("Company").

                                       and

HOKUYO KOEKI CO.,  LTD., a corporation  organized and existing under the laws of
Japan,  having its  principal  office at 29th Fl.,  Yebisu  Garden  Place Tower,
4-20-3 Ebisu, Shibuya-Ku, Tokyo 150-6029, Japan ("Purchaser").

                                    RECITALS

A.       The  Company  intends to increase  its  paid-in  capital by issuing new
         shares of its common stock.

B.       The  Purchaser  wishes to subscribe for and purchase such new shares of
         the common stock of the Company on the terms and  conditions  contained
         herein.

NOW THEREFORE, the Company and the Purchaser agree as follows:

         I.       DEFINITIONS

In addition to those terms defined above,  the following  terms, as used herein,
shall  have the  meanings  as set forth  below,  which  shall  include  both the
singular and plural thereof:

1.1      "Common  Shares"  shall mean shares of the common stock of the Company,
         par value of 100 Won per share.

1.2      "Won" shall mean the lawful currency of the Republic of Korea.

         II.      SUBSCRIPTION OF SHARES

2.1      SUBSCRIPTION  OF SHARES.  The  Company  shall  issue and deliver to the
         Purchaser,  and the Purchaser shall subscribe for and purchase  803,220
         Common Shares at 4,980 Won per share.

2.2      PAYMENT.  In  consideration  of the  subscription  and  purchase of new
         shares as  provided  in Section  2.1,  the  Purchaser  shall pay to the
         Company  4,000,035,600  Won by means of wire  transfer  of  immediately
         available funds into the bank account,





         designated by the Company on March 22, 2002.  After confirming that the
         entire  amount  of  4,000,035,600  Won  has  been  deposited  into  the
         designated  bank  account,  the Company  shall issue to the Purchaser a
         receipt for the payment.

2.3      ISSUANCE OF  CERTIFICATES.  After  completing the  registration  of the
         capital  increase,  the  Company  shall  request  the Korea  Securities
         Depository to issue the share  certificates of 803,220 Common Shares to
         the Purchaser.  The Purchaser  shall deposit the share  certificates to
         the Korea  Securities  Depository and then shall not withdraw the share
         certificates for one (1) year from the date when the share certificates
         are issued.

         III.     MISCELLANEOUS

3.1      ENTIRE AGREEMENT.  This Agreement  constitutes the entire agreement and
         supersedes any prior understandings,  agreements, or representations by
         or between  the  Company  and the  Purchaser,  written or oral,  to the
         extent they relate in any way to the subject matter hereto.

3.2      GOVERNING  LAW.  This  Agreement  shall be governed by and construed in
         accordance with the Laws of the Republic of Korea.

IN WITNESS WHEREOF,  the Company and the Purchaser have caused this Agreement to
be duly executed by their respective  officers duly authorized as of the day and
year first above written.


COMPANY:


EUGENE SCIENCE INC.


By:        /S/ SEUNG-KOWN NOH
         --------------------------------
Name:    Seung-Kwon Noh
Title:   President


PURCHASER:

HOKUYO KOEKI CO., LTD.


By:       /S/ KOICHI MURAMATSU
         --------------------------------
Name:    Koichi Muramatsu
Title:   President and Representative Director